What are the long term side effects Ibrance or Palbociclib for Breast Cancer | Onco Power скачать в хорошем качестве

What are the long term side effects Ibrance or Palbociclib for Breast Cancer | Onco Power

What are the long term side effects Ibrance or Palbociclib for Breast Cancer | Onco Power This video answers the question "What are the long term side effects Ibrance or Palbociclib for Breast Cancer?" Subscribe to Our Channel :    / @oncopower2732   👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️ Ibrance (palbociclib) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Ibrance is used to treat breast cancer. Ibrance is usually given after other cancer medications have been tried without success. The long-term side effects of Ibrance are not yet known. This video describes what is currently known about the possible risks associated with this drug and lists some of the short-term side effects that have been reported. What is Ibrance or Palbociclib? Ibrance (palbociclib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Ibrance is used to treat breast cancer that has spread to other parts of the body in women who have already been treated with certain other medications (letrozole or anastrozole). Ibrance is usually given after other cancer medications have been tried without success. Ibrance may also be used for purposes not listed in this medication guide. How does it work? Ibrance (palbociclib) is a prescription medicine used to treat breast cancer that has spread to other parts of the body (metastatic). Ibrance is a cancer chemotherapy medicine that works by slowing or stopping the growth of cancer cells. Ibrance is used: -In combination with letrozole, as initial endocrine-based therapy for postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer -In combination with fulvestrant, as endocrine-based therapy for women with HR-positive, HER2-negative metastatic breast cancer who have received prior endocrine therapy -Alone in people whose tumors express the CDK4/6 biomarker and who have received one or more prior endocrine therapies What are the potential side effects? There are several potential side effects associated with Ibrance or Palbociclib for Breast Cancer treatment. These include: -Fatigue -Nausea and vomiting -Diarrhea -Decreased appetite -Weight loss -Constipation -Anemia -Low blood counts -Skin rash -Mouth sores -Hair loss Long-term side effects There are a number of potential long-term side effects associated with Ibrance or Palbociclib for breast cancer. These include: • an increased risk of developing another primary cancer (e.g. of the uterus or ovaries); • an increased risk of developing blood clots; • an increased risk of developing bone problems; • an increased risk of developing heart problems; • an increased risk of developing complications from radiation therapy; and, • an increase in the severity of hot flashes and night sweats. Conclusion While Ibrance and Palbociclib are generally well tolerated, some women may experience long term side effects from these drugs. These side effects can include fatigue, low blood counts, nerve damage, and heart problems. If you are experiencing any of these side effects, be sure to talk to your doctor so that they can help you manage them. For cancer Related questions, contact your doctor or ask an Oncologist through our app at OncoPower.org Follow and Support the OncoPower Community : APP STORE: https://apps.apple.com/us/app/oncopow... GOOGLE PLAY: https://play.google.com/store/apps/de... WEBSITE: https://oncopower.org/ FACEBOOK:   / oncopower.io​   TWITTER: https://twitter.com/oncopower?lang=en​ 👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️👨‍⚕️⚕️